Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
出版年份 2020 全文链接
标题
Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
作者
关键词
Hepatocellular carcinoma, 3D bio-printing, Drug screening, Patient-specific treatment
出版物
BIOMATERIALS
Volume 265, Issue -, Pages 120416
出版商
Elsevier BV
发表日期
2020-09-22
DOI
10.1016/j.biomaterials.2020.120416
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bioprinting: From Tissue and Organ Development to in Vitro Models
- (2020) Carlos Mota et al. CHEMICAL REVIEWS
- Establishment of a PDX tumor from Hepatitis C Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy
- (2020) Mustafa Nazzal et al. HEPATOLOGY
- Establishment and Preclinical Therapy of Patient-derived Hepatocellular Carcinoma Xenograft Model
- (2020) Yuwei Wu et al. IMMUNOLOGY LETTERS
- Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research
- (2020) Lejia Sun et al. Frontiers in Oncology
- Surgical resection plus radiofrequency ablation for the treatment of multifocal hepatocellular carcinoma
- (2019) Cheng Zhou et al. HEPATOBILIARY SURGERY AND NUTRITION
- Volumetric additive manufacturing via tomographic reconstruction
- (2019) Brett E. Kelly et al. SCIENCE
- A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy
- (2019) Hee-Gyeong Yi et al. Nature Biomedical Engineering
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Multivascular networks and functional intravascular topologies within biocompatible hydrogels
- (2019) Bagrat Grigoryan et al. SCIENCE
- Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinoma
- (2019) Zhen-Li Li et al. HEPATOBILIARY SURGERY AND NUTRITION
- Liver organoids: from basic research to therapeutic applications
- (2019) Nicole Prior et al. GUT
- 3D bioprinting of collagen to rebuild components of the human heart
- (2019) A. Lee et al. SCIENCE
- Cancer modeling meets human organoid technology
- (2019) David Tuveson et al. SCIENCE
- Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels
- (2019) Mark A. Skylar-Scott et al. Science Advances
- Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer
- (2018) Eliza Li Shan Fong et al. BIOMATERIALS
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- 3D printed tissue engineered model for bone invasion of oral cancer
- (2018) Thafar Almela et al. TISSUE & CELL
- Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries
- (2018) Hongmei Zeng et al. Lancet Global Health
- 3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade
- (2018) Amir R. Aref et al. LAB ON A CHIP
- Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
- (2018) Sandro Nuciforo et al. Cell Reports
- Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents
- (2017) Qiang Gao et al. GASTROENTEROLOGY
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
- (2017) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
- (2017) Laura Broutier et al. NATURE MEDICINE
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
- (2017) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line
- (2016) Phyllis F. Y. Cheung et al. Cancer Cell International
- Heterogeneity of liver cancer and personalized therapy
- (2016) Liang Li et al. CANCER LETTERS
- US cancer institute to overhaul tumour cell lines
- (2016) Heidi Ledford NATURE
- Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer
- (2016) Yoon Young Choi et al. Scientific Reports
- Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma
- (2015) Weining Wang et al. BMC CANCER
- Liver cancer: Approaching a personalized care
- (2015) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Additive manufacturing techniques for the production of tissue engineering constructs
- (2012) Carlos Mota et al. Journal of Tissue Engineering and Regenerative Medicine
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo
- (2011) Shu Tian et al. CANCER SCIENCE
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- (2010) A. McKenna et al. GENOME RESEARCH
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- Human microvasculature fabrication using thermal inkjet printing technology
- (2009) Xiaofeng Cui et al. BIOMATERIALS
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More